 |
Summary of Results
23 Studies of PCB Effects and Human Immune System Disorders
(Each entry represents one finding in a study --- unless
otherwise noted. Some studies had multiple findings.)
All 23 studies summarized below showed some aspect of immune system
disorders caused by PCB exposure. Keep in mind that not all studies
are equal in size or quality. Some examine the effects of old PCB commercial
mixtures (which had variable composition), or just one or two individual
types of PCBs (out of 209 possible.) This accounts for some of the varying
results. It’s clear that not all PCBs have the same effects and only some
are immunotoxic. Some of the studies are from the 1970s when scientists
were just learning about immune effects. Some studies use high and some
use low doses of PCBs. In some cases, the exact PCB dose was unknown. The
types of PCBs which have lingered in our area and accumulated in Fox River
and Green Bay fish are likely to be the more toxic and persistent PCB types.
-
background levels of PCB/dioxin exposure influences the human fetal and
neonatal immune system. (2 studies)
-
background levels of organochlorine compounds through the breast milk influences
the human neonatal immune system (3 studies)
-
chlorinated dioxins and related chemicals from the breast milk correlated
negatively with the percentages of CD8 positive lymphocytes
-
increase in the total number of T cells
-
increase in the number of TcR gamma delta+ T cells
-
increased in the number of CD8+ (cytotoxic), TcR alpha beta+, and TcR gamma
delta+ T cells
-
lower monocyte and granulocyte counts
-
no relationship between pre- and postnatal PCB/dioxin exposure and upper
or lower respiratory tract symptoms or humoral antibody production
-
PCBs are linked to long-term immune effects (decades after poisoning)
-
autoantibodies in patients with Yusho PCB poisoning are frequent --- (which
may make them vulnerable to autoimmune disorders)
-
45.6% of PCB poisoned patients showed antinuclear antibodies, 12.7% rheumatoid
(arthritis) factor and 11.1% thyroglobulin antibodies
-
serum levels of immunoglobulin A(IgA), immunoglobulin G(IgG) and immunoglobulin
M(IgM) were elevated in 12.7%, 24.1% and 8.9% respectively in PCB poisoned
patients
-
thyroglobulin antibody was detected in 19.5% of people with higher PCB
exposures
-
mean absolute density of CD4 positive lymphocytes was higher
-
increased levels of dioxins and related compounds (PCBs) correlate with
negative changes in lymphocyte subpopulations and CD4+/CD8+ biomarkers
-
dioxin and related compounds may be related to immunopathy, such as atopic
dermatitis
-
PCB poisoned children suffer increased rates of bronchitis, respiratory
tract and ear infections, and influenza attacks
-
suppressed immunity was not demonstrated with serum immunologic marker
analyses
-
immune functional tests may be necessary to detect changes (such as delayed
hypersensitive skin reaction, in vitro lymphocyte proliferation, and antibody
synthesis following immunization)
-
impaired immune functioning may result in neuropsychological impairment
(brain damage)
-
non-Hodgkin’s lymphoma (NHL) risk increases in humans with immune deficiencies
or autoimmune disorders
-
non-Hodgkin’s lymphoma has been associated with PCB exposure (2 studies)
-
non-Hodgkin’s lymphoma may result from a combination of chemical immunosuppression
and virus infection
-
eliminating PCB exposures could help prevent non-Hodgkin’s lymphoma
-
organochlorines have been reported to adversely affect the human immune
system, reducing defenses against cancer
-
immune damage combined with estrogenic qualities (as with PCBs) have been
linked to breast cancer
-
prenatal organochlorine exposure could be a risk factor for increased ear
infections in infants
-
higher incidence of bacterial infections in babies of PCB exposed mothers
-
increased respiratory symptoms correlated with PCB exposure in poisoned
humans, along with viral or bacterial infections
-
immunoglobulin-A and immunoglobulin-M levels were decreased, while immunoglobulin-G
level was increased
-
PCB caused suppression of cellular immunity such as the delayed-type skin
response to streptokinase and streptodornase
-
changes of lymphocyte subpopulations may be responsible for immune deficiency
due to PCBs
-
percentages of total T cells, active T cells and Tmu cells decreased (2
studies)
-
decreased concentrations of IgA and IgM but not that of IgG (2 studies)
-
ratios of CD4+ to CD8+ T cells showed significant increasing tendency correlated
with organochlorine exposure
-
decreased concentration of IgM and IgA but not of IgG
-
decreased percentage of total T-cells, active T-cells, and helper T-cells
-
normal percentage of B-cells and suppressor T-cells
-
suppression of delayed type response to recalling antigens
-
enhancement of lymphocyte spontaneous proliferation
-
significantly lower PHA and ConA lymphocyte stimulation values
-
release of soluble CD23 (Fc epsilon RII) was higher
-
thrombocyte aggregation, serotonin release and 12-HETE formation
-
weekly intake of fatty fish correlated negatively with proportions of natural
killer (NK) cells
-
significant negative correlations between numbers of NK cells and blood
levels of PCB 126
-
secretory immunoglobulin A is strongly affected
-
increased readiness for allergic respiratory disease, through the proof
of hyperreactive mucous membranes
-
PCB 104 induced DNR fragmentation and killed human monocytic cells (parts
of the immune system) through an unknown mechanism independent of the arylhydrocarbon
(Ah) receptor
-
PCB 104 decreased cell viability and induced cellular morphologic features
characteristic of cell death such as chromatin aggregation and apoptotic
bodies
-
PCB 126 (dioxin-like PCB) did not kill monocytes, but potently induced
CYP 1A1 in human hepatoma Hep G2 cells
-
thymic atrophy
-
reduced thymocytes
-
it should be possible to develop dioxin Toxic Euivalency Factors (TEFs)
for PCBs causing immune system damage
-
inhibition of glucose uptake in human leukocytes by PCB Aroclor-1254 appears
to be independent of adenosine-triphosphatase inhibition
-
certain PCB types had no effects on mitogen-induced DNA synthesis and immunoglobulin
synthesis by lymphocytes
-
interference with E-rosette formation and human T-lymphocyte function
-
direct action on lymphocytes, for example, interference with epitopes of
the CD 2-receptor or specific membrane function
-
PCB immune effects were consistent with the delayed type of hypersensitivity
reaction seen in humans
-
PCB commercial mixture Aroclor 1254 inhibits uptake of lymphocyte DG and
monocyte DG (2 types of leukocytes)
-
research methods have been developed to study PCB impacts on human leukocytes
-
tests have been created to selectively identify and quantify PCBs 77, 126
and 169
Back to top
Summary of 45 Study Reviews
(Each entry represents one finding in a study --- unless
otherwise noted. Some studies had multiple findings.)
All but one of the 45 reviews listed below indicate that PCBs are believed
to be toxic to at least some portions of the human immune system.
-
extensive evidence has accumulated over 20 years showing immune systems
of several species are a target for PCB toxicity
-
there is no "safe" level of PCB exposure --- any PCB exposure could carry
risk, no matter how small the exposure
-
dioxins and dioxin-like chemicals (like PCBs) are present in the environment,
food chain and body tissues at doses at or near levels supposed to cause
harm to public health
-
background exposure levels of PCBs may change the T-cell population
-
non-cancer effects of chemical exposure may occur at low concentrations
-
to achieve human consumption levels close to zero-PCBs would require prohibition
of important foods, such as fish
-
political judgements are made to balance public health protection with
the need to prevent "excessive losses of food" (ie: fish consumption warnings
are weaker than a pure public health warning would require)
-
dioxin is the common name for a series of 75 dibenzodioxins, 135 dibenzofurans
and 209 PCBs.
-
PCBs are one of the 12 worst Persistent Organic Pollutants (POPs) identified
by the United Nations Environment Program as requiring urgent regulatory
attention
-
POPs are known to play a role in immune system dysfunction and greater
susceptibility to disease
-
All of the POPs are closely related Chlorinated Organic Compounds
-
immune system changes occur at dioxin doses one-tenth to one-hundredth
of the cancer-causing dose (certain PCBs are dioxin-like)
-
environmental chemicals that modify the immune functions may also interact
with chemical carcinogens
-
the immune system can provide significant deterrants to cancer
-
immune suppression may increase the risk of tumors or cancer
-
some chemicals promote tumors indirectly by altering the functions of the
immune system
-
PCBs promote tumors by this method
-
PCBs have been shown to alter tumor transplantation resistance
-
PCBs and dioxins may affect primary antibody response
-
alterations in lymphocyte subpopulations
-
one biomarker (test) for this effect measures the CD4/CD8 ratio (a measure
of certain lymphocytes)
-
immune system damage is more dramatic and persistent for PCB exposed fetuses
and babies, as opposed to PCB exposed adults (2 studies)
-
autoimmune and hypersensitivity disorders diseases may be linked to early
exposure to immunotoxicant chemicals
-
PCBs are associated with autoimmunity and immune enhancement
-
immunosuppression and immunodepression equal decreased resistance to viral,
bacterial, fungal, and other infectious agents or increased susceptibility
to cancer
-
immunoenhancement equals increased risk of autoimmune reactions or allergic
reactions
-
children exposed prenatally to PCBs and furans suffer increased respiratory
disease
-
atrophy of major lymphoid organs
-
apoptotic cell death may lead to altered T-B cell ratios, and loss of regulatory
cells in critical numbers leading to perturbations in immune function
-
disruption of the immune system could disrupt other vital systems, during
early development in the womb or infancy
-
immune disruption may alter reproductive functions
-
chemical regulatory programs should be reevaluated to address concerns
about non-cancer effects
-
immunotoxicity is one of the 3 main PCB effects used for risk assessment
-
it is not known how all these effects are related to functional impairment
of the immune system
-
PCBs are potent inducers of certain cytochrome enzymes
-
the PCB composition of a commercial mixture is different from the PCB composition
of the mixtures which humans will be exposed to, especially from food
-
Aroclor PCB commercial mixtures have been shown to produce immunosuppressive
effects
-
humans accidentally poisoned with PCBs suffered compromised immune system
function
-
laboratory animals show immunotoxic effects and thymus atrophy
-
the immune system is perhaps one of the most sensitive indicators for adverse
PCB-induced health effects
-
certain PCBs bind to the body’s Ah receptor, which links to the immune
system
-
immunotoxicity of one chemical can sometimes be modified by a second chemical
-
the fetus appears to be particularly vulnerable
-
different PCBs cause different effects
-
the immune systems of humans are not affected by PCBs (1993)
-
with the exception of sensitization, most of the PCB effects observed in
animals have not yet been observed in humans (1988)
-
the effect of many chemicals or their metabolites on immune function are
due to their direct effects or on lymphoid tissues.
-
a single assay of immune function may not be appropriate to detect chemical
induced immune dysfunction
-
in 1974, scientists already had evidence of PCBs causing immune system
damage
-
immunotoxicity is one of the most significant health effects of dioxins
-
a number of PCBs (the planar and the mono-ortho planar PCBs) cause effects
corresponding with those of the 2,3,7,8-PCDDs (dioxins) and PCDFs (furans)
-
immunotoxicity studies produce variable results, using a wide variety of
measures
-
a broad database of normal human immunological endpoints needs to be established
for use in immunotoxicity assessments
-
chemical exposures may lead to immunosuppression, immunopotentiation, hypersensitivity
or perturbed innate host resistance
-
No one infectious model has yet emerged as a routine screening tool to
detect and assess the subtle effects that may occur in immune responses
-
effects on the immune system have been demonstrated in the low dose range
but clear dose-effect relationships are lacking
-
immunological effects have been demonstrated in humans but data so far
do not allow any quantitative conclusions to be drawn. Due to the lack
of quantitative data from studies in humans, risk assessments have to be
based on experimental animal data
-
observed immune changes are usually slight and do not allow firm predictions
of health effects
-
the capacity of chemicals to trigger autoimmune diseases in humans is poorly
studied because of basic research method difficulties
-
non-invasive tests of humans are limited
-
responses in the human population are heterogenous (we each have different
genetic susceptibilities, so we each respond differently)
-
exposure levels are often low (which may make effects more subtle, infrequent
or difficult to detect)
-
workplace exposures to toxins affecting the blood-forming and immune systems
are of basic importance
-
immunotoxicity of PCBs is a concern in silicone oil used in eye operations
-
more studies are needed
Other pages in this Immunity section:

|